| scholarly article | Q13442814 |
| review article | Q7318358 |
| historical article | Q58901470 |
| P2093 | author name string | Wolfram H Gerlich | |
| P2860 | cites work | Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. | Q45368504 |
| N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. | Q45370624 | ||
| Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes | Q45388354 | ||
| Statements from the Taormina expert meeting on occult hepatitis B virus infection | Q45391959 | ||
| Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus | Q21128797 | ||
| Summary statement of the Asilomar conference on recombinant DNA molecules | Q24564504 | ||
| Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin | Q24676087 | ||
| Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma | Q28287494 | ||
| Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues | Q28321734 | ||
| Dating the origin and dispersal of hepatitis B virus infection in humans and primates | Q30421361 | ||
| Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. | Q31132087 | ||
| A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes | Q33669396 | ||
| Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus | Q33851722 | ||
| Antiviral chemotherapy for the treatment of hepatitis B virus infections | Q33951469 | ||
| Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection | Q34046044 | ||
| Virus-like particles in serum of patients with Australia-antigen-associated hepatitis | Q34051789 | ||
| Immunisation against hepatitis B in man | Q34054345 | ||
| Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan | Q34054719 | ||
| The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses | Q34111026 | ||
| Self-replication and scrapie | Q34225002 | ||
| Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines | Q34229091 | ||
| Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus | Q34288062 | ||
| The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. | Q34318146 | ||
| Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. | Q45722147 | ||
| Experimental infection of chimpanzees with the virus of hepatitis B. | Q45728763 | ||
| An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques | Q45737487 | ||
| Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients | Q45784197 | ||
| Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand | Q45790971 | ||
| Synthesis and assembly of hepatitis B virus surface antigen particles in yeast | Q45793098 | ||
| Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis???associated antigen | Q45813157 | ||
| Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody | Q45816010 | ||
| Subtypes of Australia antigen and hepatitis-B virus | Q45827015 | ||
| The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen | Q45831285 | ||
| Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus | Q45836434 | ||
| A new antigen complex co-occurring with Australia antigen | Q45856047 | ||
| Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis | Q45886480 | ||
| Molecular epidemiology of hepatitis B in the Indigenous people of northern Australia. | Q46197619 | ||
| Outbreak of hepatitis B in a nursing home associated with capillary blood sampling | Q46912934 | ||
| Nucleic acid testing to detect HBV infection in blood donors. | Q50548264 | ||
| Human hepatitis B vaccine from recombinant yeast | Q52850114 | ||
| Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. | Q52852334 | ||
| Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. | Q53717794 | ||
| Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. | Q53732725 | ||
| D.N.A. polymerase in preparations containing Australia antigen. | Q54038990 | ||
| No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. | Q54438215 | ||
| Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of "virus hepatitis" | Q67069901 | ||
| Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein | Q68303059 | ||
| New antigen-antibody system in Australia-antigen-positive hepatitis | Q70033669 | ||
| [Hepatitis-associated antigen: purification and properties] | Q70039720 | ||
| Relation of Australia and SH antigens | Q70090831 | ||
| Expression of hepatitis B surface antigen in yeast | Q71143056 | ||
| A preliminary trial of lamivudine for chronic hepatitis B infection | Q71523548 | ||
| Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States | Q72150100 | ||
| The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence | Q74196064 | ||
| Viral hepatitis, type B (MS-2 strain). Studies on active immunization | Q93825904 | ||
| The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses | Q34343473 | ||
| Infection of a human hepatoma cell line by hepatitis B virus | Q34388628 | ||
| Viral hepatitis: global goals for vaccination | Q34418925 | ||
| Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers | Q34439649 | ||
| Subgenotyping of genotype C hepatitis B virus: correcting misclassifications and identifying a novel subgenotype. | Q34450684 | ||
| gp180, a protein that binds duck hepatitis B virus particles, has metallocarboxypeptidase D-like enzymatic activity | Q34462491 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. | Q34596607 | ||
| Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model | Q34778476 | ||
| Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen | Q35019340 | ||
| Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region | Q35033602 | ||
| Recombinant hepatitis B triple antigen vaccine: Hepacare | Q35193410 | ||
| Hepatitis B vaccines | Q35621657 | ||
| Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma | Q35677500 | ||
| Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus | Q35802832 | ||
| Nuclear import of hepatitis B virus capsids and release of the viral genome | Q35813985 | ||
| 1971 International Symposium on Viral Hepatitis. Historical perspectives | Q35933466 | ||
| A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks | Q35991835 | ||
| Isolation of a hepadnavirus from the woolly monkey, a New World primate | Q36098394 | ||
| Australia antigen (a hepatitis-associated antigen): purification and physical properties | Q36270430 | ||
| Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa | Q36307687 | ||
| A virus in Beechey ground squirrels that is related to hepatitis B virus of humans | Q36390554 | ||
| Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes | Q36436398 | ||
| Further data on HBs antigen subtypes - geographical distribution | Q36504798 | ||
| Reliability of methods for hepatitis B virus DNA detection | Q36517685 | ||
| DNA of a human hepatitis B virus candidate | Q36563033 | ||
| DNA polymerase associated with human hepatitis B antigen | Q36595122 | ||
| Immunobiology and pathogenesis of viral hepatitis | Q37014739 | ||
| Hepatitis B viruses: reverse transcription a different way. | Q37109700 | ||
| Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections | Q37208680 | ||
| Cloning in Escherichia coli and physical structure of hepatitis B virion DNA | Q37330184 | ||
| Toward elimination and eradication of hepatitis B. | Q37688282 | ||
| Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association | Q37833427 | ||
| Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs | Q38067130 | ||
| Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus | Q38877747 | ||
| Integration of hepatitis B virus sequences and their expression in a human hepatoma cell | Q38982330 | ||
| Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy | Q39343481 | ||
| Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine | Q39392849 | ||
| Establishment of a continuously growing cell line from primary carcinoma of the liver | Q39414521 | ||
| Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes | Q39723280 | ||
| Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation | Q39746875 | ||
| Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions | Q39811034 | ||
| Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis | Q39875055 | ||
| The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound | Q39974472 | ||
| Isolation and characterization of a hepatitis B virus endemic in herons | Q40129333 | ||
| Large surface proteins of hepatitis B virus containing the pre-s sequence | Q40134267 | ||
| A Solid-Phase Radioimmunoassay for Detection of IgM Antibodies to Hepatitis A Virus | Q40253524 | ||
| Inhibition of hepatitis B virus replication by APOBEC3G. | Q40576734 | ||
| Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein | Q40791877 | ||
| A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army | Q40797808 | ||
| Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen | Q41039958 | ||
| Selective detection of IgM-antibody against core antigen of the hepatitis B virus by a modified enzyme immune assay | Q41171148 | ||
| Hepatitis B virus genes and their expression in E. coli | Q41200439 | ||
| Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. | Q41205751 | ||
| Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA | Q41206745 | ||
| Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. | Q41277179 | ||
| Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection | Q41604155 | ||
| Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen | Q41752031 | ||
| Infectivity of blood products from donors with occult hepatitis B virus infection | Q42277057 | ||
| Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor | Q42474064 | ||
| A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection | Q42606604 | ||
| The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator | Q42631282 | ||
| Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography | Q42990858 | ||
| Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. | Q43047565 | ||
| A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant | Q43440714 | ||
| Antibody to hepatitis-B-virus core in man. | Q43499443 | ||
| Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies. | Q43667277 | ||
| Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. | Q44135004 | ||
| Detection of additional antigenic determinants of hepatitis B antigen | Q44241143 | ||
| Cloned HBV DNA causes hepatitis in chimpanzees | Q44284928 | ||
| Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate | Q44294970 | ||
| Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. | Q44523537 | ||
| Immunogenicity of combined hepatitis A and B vaccine in elderly persons | Q44638089 | ||
| Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient | Q45352889 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B vaccine | Q117749 |
| laboratory diagnostics | Q1799491 | ||
| Hepatitis B virus | Q6844 | ||
| hepatitis B | Q6853 | ||
| virology | Q7215 | ||
| hepatitis b virus hbsag surface protein antigen | Q28859738 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 239 | |
| P577 | publication date | 2013-07-20 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | Medical virology of hepatitis B: how it began and where we are now | |
| P478 | volume | 10 |
| Q43620287 | 25 years of Hepatitis C. |
| Q37740476 | A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea. |
| Q52654932 | ADCC-Mediated CD56DIM NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection. |
| Q47574790 | Advanced Strategies for Eliminating the cccDNA of HBV. |
| Q42318295 | Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation |
| Q26773213 | Alcohol and Viral Hepatitis: Role of Lipid Rafts |
| Q26995164 | Anti-cancer vaccines - a one-hit wonder? |
| Q59349509 | Assessment of knowledge, attitude, and practices toward prevention of hepatitis B infection among medical students in a high-risk setting of a newly established medical institution |
| Q37586253 | Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma |
| Q91641667 | Association of fatty liver disease with mortality outcomes in an Eastern Finland male cohort |
| Q26781812 | Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review) |
| Q92015272 | Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population |
| Q41224087 | Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000. |
| Q98772865 | COVID-19 vaccines: ethical framework concerning human challenge studies |
| Q40580426 | CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X. |
| Q39108465 | Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes. |
| Q90481054 | Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer |
| Q38588576 | Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders |
| Q36162866 | Detection of hepatitis B virus infection: A systematic review |
| Q35059029 | Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria |
| Q40189385 | Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells |
| Q90227288 | Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis |
| Q38306933 | Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine |
| Q35856092 | Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. |
| Q92256983 | Evaluation of HBV-Like Circulation in Wild and Farm Animals from Brazil and Uruguay |
| Q38778496 | Experimental models of hepatitis B and C - new insights and progress |
| Q107392235 | Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies |
| Q92881172 | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms |
| Q33559657 | Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies |
| Q38773364 | Hepatitis B immunopathogenesis and immunotherapy |
| Q40163233 | Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro |
| Q30235028 | Hepatitis B virus and its sexually transmitted infection - an update |
| Q33594925 | Hepatitis B virus genetic mutations and evolution in liver diseases |
| Q28657861 | Hepatitis B virus infection in Latin America: a genomic medicine approach |
| Q56944581 | Hepatitis B virus infection: Defective surface antigen expression and pathogenesis |
| Q35055364 | Hepatitis B virus large surface protein: function and fame. |
| Q33911464 | Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity |
| Q35724726 | Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya |
| Q33721413 | Hepatitis B virus seroprevalence among Malawian medical students: A cross-sectional study |
| Q40042818 | Hepatitis delta: virological and clinical aspects |
| Q42208374 | Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry. |
| Q40285362 | High rate of Hepatitis B virus infection among hairdressers in Ibadan, Nigeria |
| Q40409344 | In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV RNaseH Inhibitors |
| Q24289253 | Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research |
| Q35750696 | Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice |
| Q91583964 | Liver-Mediated Adaptive Immune Tolerance |
| Q38255751 | MICA SNPs and the NKG2D system in virus-induced HCC. |
| Q90417668 | Molecular evolution and genomics of hepatitis B virus subgenotype C2 strain predominant in the chronic patients in Bangladesh |
| Q35119270 | Mutations and CpG islands among hepatitis B virus genotypes in Europe |
| Q40295939 | Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives |
| Q40351702 | New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen. |
| Q89551187 | Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi |
| Q35803361 | Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection |
| Q35127050 | Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance |
| Q36476043 | Occult hepatitis B virus infection: influence of S protein variants |
| Q28075646 | Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis |
| Q45326294 | Patterns of serologic markers of hepatitis B virus infection and the risk of transmission among pregnant women in southwestern Nigeria |
| Q89565252 | Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings |
| Q37656008 | Poor sensitivity of rapid tests for the detection of antibodies to the hepatitis B virus: implications for field studies |
| Q38293584 | Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives |
| Q49809812 | Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma |
| Q38263846 | Recent advances in molecular diagnostics of hepatitis B virus |
| Q38815666 | Replication of a chronic hepatitis B virus genotype F1b construct. |
| Q90243326 | Restoring, releasing or replacing adaptive immunity in chronic hepatitis B |
| Q61798987 | Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymerase |
| Q90607894 | Role of alcohol in pathogenesis of hepatitis B virus infection |
| Q39238511 | Significance of anti-HBc alone serological status in clinical practice |
| Q98158909 | THE IMPACT OF POSITIVE ANTI-HBC MARKER ON PERMANENT DEFERRAL OF VOLUNTARY BLOOD DONORS IN EASTERN CROATIA AND ESTIMATION OF OCCULT HEPATITIS B VIRUS INFECTION RATE |
| Q91924867 | The Role of Hepatitis B Core-Related Antigen |
| Q47252754 | The Role of Tumor Microenvironment in Cancer Immunotherapy. |
| Q38812202 | The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo |
| Q42048428 | The Structural Biology of Hepatitis B Virus: Form and Function |
| Q40676461 | The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state |
| Q51070825 | Therapeutic vaccination in chronic hepatitis B--approaches, problems, and new perspectives. Preface. |
| Q36269684 | Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma. |
| Q40990518 | United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015. |
| Q91964365 | Utility of oral fluid samples for hepatitis B antibody detection in real life conditions |
| Q104494546 | Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines |
| Q35045045 | Viral hepatitis: past and future of HBV and HDV. |
| Q38685589 | Virological and serological tools to optimize the management of patients with chronic hepatitis B. |
Search more.